Prosecution Insights
Last updated: August 18, 2026

Examiner: HENLEY III, RAYMOND J

Tech Center 1600 • Art Units: 1614 1629 1652

This examiner grants 84% of resolved cases

Performance Statistics

83.5%
Allow Rate
+23.5% vs TC avg
1,300
Total Applications
+2.3%
Interview Lift
694
Avg Prosecution Days
Based on 1253 resolved cases, 2023–2026

Rejection Statute Breakdown

6.2%
§101 Eligibility
9.0%
§102 Novelty
21.1%
§103 Obviousness
32.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19572691 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL Non-Final OA Veradermics, Incorporated
19542655 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL Non-Final OA Veradermics, Incorporated
19444686 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL Non-Final OA Veradermics, Incorporated
19443936 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL Non-Final OA Veradermics, Incorporated
19442979 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL Non-Final OA Veradermics, Incorporated
19442911 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL Non-Final OA Veradermics, Incorporated
19442899 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL Non-Final OA Veradermics, Incorporated
19442974 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL Non-Final OA Veradermics, Incorporated
19441484 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL Non-Final OA Veradermics, Incorporated
19436869 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL Non-Final OA Veradermics, Incorporated
19432541 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL Non-Final OA Veradermics, Incorporated
19430093 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL Non-Final OA Veradermics, Incorporated
19430022 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL Non-Final OA Veradermics, Incorporated
19427955 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL Non-Final OA Veradermics, Incorporated
19427815 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL Non-Final OA Veradermics, Incorporated
19329476 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL Final Rejection Veradermics, Incorporated
19328077 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL Final Rejection Veradermics, Incorporated
19324046 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL Final Rejection Veradermics, Incorporated
19308124 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL Final Rejection Veradermics, Incorporated
19303300 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL Non-Final OA Veradermics, Incorporated
19267447 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL Non-Final OA Veradermics, Incorporated
19267464 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL Non-Final OA Veradermics, Incorporated
19260035 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL Non-Final OA Veradermics, Incorporated
19258817 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL Non-Final OA Veradermics, Incorporated
19255878 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL Non-Final OA Veradermics, Incorporated
19242858 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL Non-Final OA Veradermics, Incorporated
19241304 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL Non-Final OA Veradermics, Incorporated
19236933 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL Non-Final OA Veradermics, Incorporated
19235535 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL Non-Final OA Veradermics, Incorporated
19234212 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL Non-Final OA Veradermics, Incorporated

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month